{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-030140","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2023-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.006420+00:00","generated_at":"2026-06-11T03:33:54.381491+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intelligent Bio Solutions Q4 FY2023 revenue up 355% to $1.99M; net loss widens to $10.6M","bullets":["Combined revenue & govt support income $1.99M (+355% YoY); product sales $1.26M.","Net loss attributable to INBS $10.6M (vs $8.3M prior year); includes $4.2M goodwill impairment.","Cash and equivalents $1.5M at June 30, 2023.","Received FDA guidance for 510(k) pathway for its Intelligent Fingerprinting Drug Screening Cartridge.","Expanded into Australia; secured 8 new customers; awarded 13th patent."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-030140","json":"https://secwatch.observer/filing/0001493152-23-030140.json","markdown":"https://secwatch.observer/filing/0001493152-23-030140.md","text":"https://secwatch.observer/filing/0001493152-23-030140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223030140/0001493152-23-030140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223030140/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T03:33:54.381491+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"af75732041553657db75fe1c4fb78489aaecbf1a","claim":"INTELLIGENT BIO SOLUTIONS INC. reported fiscal year ended June 30, 2023 results: revenue $1.99 million, net income $10.6 million loss.","evidence_excerpt":"The Company’s combined revenue and government support income increased by 355% to $1.99 million for the fiscal year ended June 30, 2023, including revenue from sales of goods of $1.26 million, compared to fiscal year 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223030140/0001493152-23-030140-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended June 30, 2023"},{"label":"Revenue","value":"$1.99 million"},{"label":"Net income","value":"$10.6 million loss"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}